Flexion Therapeutics - About the company
Flexion Therapeutics is an acquired company based in Woburn (United States), founded in 2007 by Neil Bodick and Mike Clayman. It operates as a Developer of therapies for the treatment of musculoskeletal disorders. Flexion Therapeutics has raised $62M in funding from Versant Ventures and Novo Holdings. The company has 307 active competitors, including 85 funded and 75 that have exited. Its top competitors include companies like Formation Bio, Cara Therapeutics and Eliem Therapeutics.
Company Details
Developer of therapies for the treatment of musculoskeletal disorders. The company is currently advancing a portfolio of injectable drug candidates that have the potential to provide better and more persistent analgesia compared with existing therapies. Their lead program, FX006, is an intra-articular sustained-release steroid injectable for patients with moderate to severe osteoarthritis (OA) pain. They also have two additional product candidates FX007, a locally administered TrkA receptor antagonist for post-operative pain, and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor for end-stage OA patients.
- Website
- flexiontherapeutics.com
- Social
- Email ID
- *****@flexiontherapeutics.com
- Registered Address
- Parsippany, New Jersey
Key Metrics
Founded Year
2007
Location
Woburn, United States
Stage
Acquired
Total Funding
$62M in 4 rounds
Latest Funding Round
Investors
Ranked
1st among 307 active competitors
Annual Revenue
$85.6M as on Dec 31, 2020
Employee Count
692 as on Dec 31, 2022
Similar Companies
Exit Details
Acquired by Pacira (Oct 11, 2021)
Legal entities associated with Flexion Therapeutics
Flexion Therapeutics is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
$85.6M (as on Dec 31, 2020) | - | - | ||
Dec 26, 999 | - | 692 (as on Dec 31, 2022) | - |
Flexion Therapeutics's acquisition details
Flexion Therapeutics got acquired by Pacira on Oct 11, 2021 at an acquisition amount of $425M. It was facilitated by Lazard.
Click here to take a look at Flexion Therapeutics's acquisition in detail
Sign up to download Flexion Therapeutics' company profile
Flexion Therapeutics's funding and investors
Flexion Therapeutics has raised a total funding of $62M over 4 rounds. Its first funding round was on Oct 16, 2009. Flexion Therapeutics has 7 institutional investors.
Here is the list of recent funding rounds of Flexion Therapeutics:
Filter this list
Filter this listDate of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 2017 | 1067376 | Post IPO | 7747183 | 5823473 | 2419303 | 3321878 |
Apr 2017 | 7054884 | Post IPO | 4923778 | 4582047 | 5372427 | 6123258 |
Dec 04, 2012 | 2369533 | Series B | 4649210 | 5554910 |
Access funding benchmarks and valuations. Sign up today!View details of Flexion Therapeutics's funding rounds and investors
Flexion Therapeutics' founders and board of directors
Founder? Claim ProfileThe founders of Flexion Therapeutics are Neil Bodick and Mike Clayman.
Here are the details of Flexion Therapeutics' key team members:
- Neil Bodick: Former Co-Founder & CSO of Flexion Therapeutics and founder of 1 other company. Contact Info: 1 email address
- Mike Clayman: Former Co-Founder & CEO of Flexion Therapeutics.
View details of Flexion Therapeutics's Founder profiles and Board Members
Flexion Therapeutics' employee count trend
Flexion Therapeutics has 692 employees as of Dec 22. The total employee count is 15.0% more than what it was in Dec 21. Here is Flexion Therapeutics's employee count trend over the years:
Uncover Flexion Therapeutics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Flexion Therapeutics's Competitors and alternates
Top competitors of Flexion Therapeutics include Formation Bio, Cara Therapeutics and Eliem Therapeutics. Here is the list of Top 10 competitors of Flexion Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Flexion Therapeutics 2007, Woburn (United States), Acquired | Developer of therapies for the treatment of musculoskeletal disorders | $62M | 70/100 | |
2nd |  Formation Bio 2016, New York City (United States), Series D | AI-powered drug discovery platform for various diseases | $608M | 64/100 | |
3rd |  Cara Therapeutics 2004, New York City (United States), Public | Developer of therapeutics for pain relief and inflammatory diseases | $51M | 63/100 | |
4th | _1573028700255.png) Eliem Therapeutics 2018, Boston (United States), Public | Developer of non-opioid therapies for treating chronic pain | $171M | 62/100 | |
5th | Developer of therapies for the treatment of pain and addiction | $248M | 62/100 | ||
6th |  Zogenix 2006, Emeryville (United States), Acquired | Developing drug delivery systems for treatment of CNS diseases | $149M | 61/100 | |
7th |  Trevena 2007, Philadelphia (United States), Public | Developer of GPCR ligand technology based therapeutics for cardiovascular diseases and pain | $119M | 59/100 | |
8th |  Satsuma Pharmaceuticals 2016, San Francisco (United States), Acquired | Developer of therapeutics for migraine sufferers | $74.1M | 59/100 | |
9th |  PainReform 2007, Herzliya (Israel), Public | Specialty pharmaceutical company that develops products for the treatment of pain | $12M | 58/100 | |
10th |  Eupraxia Pharmaceuticals 2012, Vancouver (CanN8ada), Public | Sustained released formulation for osteoarthritis | $2.44M | 55/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Flexion Therapeutics's competitors? Click here to see the top ones
Flexion Therapeutics's Investments and acquisitions
Flexion Therapeutics has made no investments or acquisitions yet.
Reports related to Flexion Therapeutics
Here is the latest report on Flexion Therapeutics's sector:
News related to Flexion Therapeutics
Filter this listMedia has covered Flexion Therapeutics for a total of 2 events in the last 1 year, 2 of them have been about partnerships.
•
EA partners with Flexion to bring mobile games to alternative app storesPocket Gamer•Mar 03, 2025•Electronic Arts, Flexion Therapeutics
•
Behind the scenes on King’s alternative store launch with FlexionMobidictum•Feb 17, 2025•Flexion Therapeutics, King
•
Ocular Therapeutix™ Appoints Steve Meyers to Chief Commercial OfficerGlobeNewswire•Feb 15, 2024•Ocular Therapeutix, Flexion Therapeutics
•
Renovacor Announces the Appointment of Fred Driscoll as Chief Financial OfficerBusiness WireSports•Mar 28, 2022•Renovacor, Flexion Therapeutics
•
Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain ManagementGlobeNewswire•Nov 19, 2021•Pacira, Flexion Therapeutics
•
Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion Therapeutics, Inc.PR Newswire•Nov 03, 2021•Kahn Swick & Foti, Flexion Therapeutics, Pacira
•
WeissLaw LLP Reminds DWSN, PAE, XLRN, and FLXN Shareholders About Its Ongoing InvestigationsPR Newswire•Nov 01, 2021•Weiss Law, Dawson Geophysical, PAE, Acceleron Pharma and 1 other
•
Monteverde & Associates PC Announces an Investigation of Flexion Therapeutics, Inc.PR Newswire•Oct 31, 2021•Monteverde, Flexion Therapeutics
•
Halper Sadeh LLP Investigates FLXN, AZPN, COLB, LMRK; Shareholders are Encouraged to Contact the FirmPR Newswire•Oct 20, 2021•Halper Sadeh, Flexion Therapeutics, AspenTech, Columbia Bank and 1 other
•
WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing InvestigationsPR Newswire•Oct 19, 2021•, Adamas Pharma, Flexion Therapeutics, AspenTech and 1 other
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Flexion Therapeutics
Explore our recently published companies
- LawyerAI - Bengaluru based, 2024 founded, Unfunded company
- MorphoGene - Morges based, 2015 founded, Unfunded company
- DR-0201 - Acquired company
- DatingProfiles.AI - Berlin based, 2024 founded, Unfunded company
- SIA Medical - Box Hill based, 1993 founded, Unfunded company
- Vourla - Tallinn based, 2019 founded, Unfunded company
